Key result
Balloon pulmonary valvuloplasty achieves ~95% procedural success and significantly lowers transvalvular gradients.
Why the study?
Long-term outcome data of balloon pulmonary valvuloplasty in infants with critical and haemodynamically significant pulmonary stenosis, especially in Latin America, remain limited.
Does balloon pulmonary valvuloplasty provide sustained haemodynamic improvement and durable long-term outcomes in children ≤24 months with critical and haemodynamically significant pulmonary stenosis?
Cohort (n=129)
No
Does balloon pulmonary valvuloplasty provide sustained haemodynamic improvement and durable long-term outcomes in children ≤24 months with critical and haemodynamically significant pulmonary stenosis?
Balloon pulmonary valvuloplasty is highly successful (94.5%) and provides durable long-term outcomes in infants ≤24 months with critical or severe pulmonary stenosis.
Supports balloon pulmonary valvuloplasty in infants ≤24 months; leaves open optimal technique and long-term durability.
Background: Balloon pulmonary valvuloplasty is the treatment of choice for critical and haemodynamically significant pulmonary stenosis, but long-term outcome data in infants, particularly in Latin America, remain limited. We evaluated long-term outcomes and factors associated with adverse outcomes in children ≤24 months. Methods: We retrospectively included consecutive patients ≤24 months who underwent balloon pulmonary valvuloplasty for critical or haemodynamically significant pulmonary stenosis between January 2004 and July 2024. Outcomes included significant restenosis, moderate-or-greater pulmonary regurgitation, pulmonary valve reintervention, and surgical reintervention. Time-to-event outcomes and predictors were assessed using Kaplan–Meier estimates and Cox regression. Results: A total of 129 patients were included (median age 1.5 months; 37.2% with critical pulmonary stenosis). Procedural success was 94.5%. The median right ventricular-to-pulmonary artery gradient decreased from 44 to 7 mmHg ( p < 0.001). During a median 7 years follow-up (interquartile range 3–10), significant restenosis occurred in 25.6%, moderate-or-greater pulmonary regurgitation in 19.4%, and 17.8% underwent pulmonary valve reintervention. Kaplan–Meier analysis demonstrated sustained freedom from adverse outcomes throughout follow-up. Univariable Cox regression identified predilation and a higher balloon-to-annulus ratio as factors associated with an increased hazard of significant restenosis and moderate-or-greater pulmonary regurgitation, whereas a larger pulmonary annulus Z -score was associated with a lower hazard of restenosis. Conclusions: Ballon pulmonary valvuloplasty is a safe and effective first-line therapy in children ≤24 months, providing sustained haemodynamic improvement and durable long-term outcomes. Patients requiring predilation, larger balloon-to-annulus ratios, or having smaller pulmonary annulus Z -scores may benefit from closer long-term echocardiographic surveillance.
No takes yet. Share an insight, caveat, or question.
Davila-Ruales et al. (2026) conducted a cohort in Critical and haemodynamically significant pulmonary valve stenosis (n=129). Balloon pulmonary valvuloplasty was evaluated on Procedural success. Balloon pulmonary valvuloplasty achieved a 94.5% procedural success rate and reduced the median right ventricular-to-pulmonary artery gradient from 44 to 7 mmHg (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: